Ticker Details
Dyne Therapeutics, Inc.
IPO Date:	September 17, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.87B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.52 | 3.24%
Avg Daily Range (30 D):	$0.46 | 2.54%
Avg Daily Range (90 D):	$0.51 | 2.90%

Institutional Daily Volume
Avg Daily Volume:	.88M
Avg Daily Volume (30 D):	1.33M
Avg Daily Volume (90 D):	1.64M

Trade Size
Avg Trade Size (Sh.):	84
Avg Trade Size (Sh.) (30 D):	64
Avg Trade Size (Sh.) (90 D):	73

Institutional Trades
Total Institutional Trades:	2,495
Avg Institutional Trade:	$2.52M
Avg Institutional Trade (30 D):	$2.7M
Avg Institutional Trade (90 D):	$2.52M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.37M
Avg Closing Trade (30 D):	$4.33M
Avg Closing Trade (90 D):	$5.03M
Avg Closing Volume:	234.27K

News

May 19, 2026 @ 5:17 PM Dyne Therapeutics Is Up 40%, but One Biotech Fund ... Source: Jonathan Ponciano

Mar 8, 2026 @ 10:01 PM Dyne Therapeutics Announces Initiation of Phase 3 ... Source: Na

Feb 22, 2026 @ 9:00 PM Dyne Therapeutics Announces Upcoming Presentations... Source: Na

Dec 10, 2025 @ 2:42 AM Dyne Therapeutics Announces Pricing of Upsized $35... Source: Dyne Therapeutics

Dec 9, 2025 @ 9:34 PM Biggest Market Movers Today, Dec. 9: WRBY, DYN, & ... Source: Dan Caplinger

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-3.19	$-.73	$-.73
Diluted EPS	$-3.19	$-.73	$-.73
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-451.71M	$-120.85M	$-111.96M
Operating Income / Loss	$-471.09M	$-125.28M	$-116.13M
Cost of Revenue
Net Cash Flow	$281.29M	$-140.25M	$320.12M
PE Ratio